Brazil vs Netherlands: HIV-positive TB patients on ART (antiretroviral therapy)
Brazil
59.0%
in 2024
Netherlands
61.0%
in 2022
Brazil rank
136th
Netherlands rank
135th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Brazil
- Netherlands
How they compare
Netherlands currently reports 61.0% against 59.0% in Brazil, a difference of 2.0%.
Across all 9 years both countries report, Netherlands has been ahead every year.
Brazil ranks 136th and Netherlands ranks 135th of 144 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.0% | 100.0% | 7.0% | Netherlands |
| 2010s | 52.2% | 63.2% | 11.0% | Netherlands |
| 2020s | 54.3% | 72.3% | 18.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Brazil or Netherlands?
- Netherlands, at 61.0% against 59.0% in Brazil as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Brazil and Netherlands?
- 2.0%, with Netherlands ahead.
- How many years of comparable data are there for Brazil and Netherlands?
- 9 years are reported by both, from 2007 to 2022.
- How do Brazil and Netherlands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Brazil ranks 136th and Netherlands ranks 135th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.